Clindamycin Phosphate

Clindamycin Phosphate Brand names, Clindamycin Phosphate Analogs

Clindamycin Phosphate Brand Names Mixture

No information avaliable

Clindamycin Phosphate Chemical_Formula

C₁₈H₃₃ClN₂O₅S

Clindamycin Phosphate RX_link

http://www.rxlist.com/cgi/generic2/clindam.htm

Clindamycin Phosphate fda sheet

Clindamycin_Phosphate FDA

Clindamycin Phosphate msds (material safety sheet)

Clindamycin Phosphate Synthesis Reference

Birkenmeyer, U.S. Pat. 3,475,407(1970)

Clindamycin Phosphate Molecular Weight

424.984 g/mol

Clindamycin Phosphate Melting Point

255 ^oC

Clindamycin Phosphate H₂O Solubility

30.6 mg/L

Clindamycin Phosphate State

Solid

Clindamycin Phosphate LogP

1.224

Clindamycin Phosphate Dosage Forms

Capsules; Intramuscular solution; Intravenousparenteral solution; Topical solution; Topical lotion; Topical gel; Vaginal cream; Vaginal ovules

Clindamycin Phosphate Indication

For the treatment of serious infections caused by susceptible anaerobic bacteria (anaerobes, streptococci, pneumococci, and staphylococci)

Clindamycin Phosphate Pharmacology

Clindamycin is an antibiotic, similar to and a derivative of lincomycin. Clindamycin can be used in topical or systemic treatment. It is effective as an anti-anaerobic antibiotic and antiprotozoal.

Clindamycin Phosphate Absorption

- 90% - oral

Clindamycin Phosphate side effects and Toxicity

Orally and parenterally administered clindamycin has been associated with severe colitis (pseudomembranous colitis) which may result in patient death. Use of the topical formulation of clindamycin results in absorption of the antibiotic from the skin surface. Diarrhea, bloody diarrhea, and colitis (including pseudomembranous colitis) have been reported with the use of topical and systemic clindamycin.

Clindamycin Phosphate Patient Information

Clindamycin Phosphate Organisms Affected

Enteric bacteria and other eubacteria